Burzynski Research Institute Inc (BZYR) reported a QQ2 2026 period with no reported revenue and a continued net loss of -$333,867. Key operating metrics show R&D expense of $255,117 and General & Administrative expense of $78,750, yielding total operating expenses of $333,867 and an EBITDA of -$333,867. Diluted EPS stood at -0.0025 on 131,448,444 weighted shares. Management commentary is not available in the provided transcript data, limiting the ability to corroborate forward-looking statements. On the balance sheet, cash at end of period was $931 (units in report), with total assets of $1,331 and current liabilities of $70,902, resulting in an extremely weak liquidity position (current ratio 0.0188) and negative stockholders’ equity of -$69,571. Cash burn from operations was modest in absolute terms (-$94,907 from operating activities), financed by a roughly $95,017 net inflow from financing activities, yielding a negligible net cash change (+$110) during the quarter.